{"id":19586,"date":"2019-12-16T16:01:00","date_gmt":"2019-12-16T16:01:00","guid":{"rendered":"http:\/\/eurojournalists.com\/?guid=7f9456f8e3904ad6937c4fb191b04f45"},"modified":"2019-12-16T16:01:00","modified_gmt":"2019-12-16T16:01:00","slug":"is-tasigna-or-nilotinib-worth-testing-for-parkinsons-shots-health-news-npr","status":"publish","type":"post","link":"https:\/\/eurojournalists.com\/?p=19586","title":{"rendered":"Is Tasigna (Or Nilotinib) Worth Testing For Parkinson&#8217;s? : Shots &#8211; Health News &#8211; NPR"},"content":{"rendered":"<ol>\n<li><a href=\"https:\/\/news.google.com\/__i\/rss\/rd\/articles\/CBMigQFodHRwczovL3d3dy5ucHIub3JnL3NlY3Rpb25zL2hlYWx0aC1zaG90cy8yMDE5LzEyLzE2Lzc4Nzk2NzQzMC9hLWNhbmNlci1kcnVnLWZvci1wYXJraW5zb25zLW5ldy1zdHVkeS1yYWlzZXMtaG9wZS1kcmF3cy1jcml0aWNpc23SAQA?oc=5\" >Is Tasigna (Or Nilotinib) Worth Testing For Parkinson&#8217;s? : Shots &#8211; Health News<\/a>&nbsp;&nbsp;<font color=\"#6f6f6f\">NPR<\/font><\/li>\n<li><a href=\"https:\/\/news.google.com\/__i\/rss\/rd\/articles\/CBMigAFodHRwczovL3d3dy5maWVyY2ViaW90ZWNoLmNvbS9yZXNlYXJjaC9ob3ctbm92YXJ0aXMtY2FuY2VyLWRydWctdGFzaWduYS1yZXN0b3Jlcy1jcml0aWNhbC1kb3BhbWluZS1zLWxvc3QtdG8tcGFya2luc29uLXMtZGlzZWFzZdIBAA?oc=5\" >How Novartis&#8217; cancer drug Tasigna restores critical dopamine that&#8217;s lost to Parkinson&#8217;s disease<\/a>&nbsp;&nbsp;<font color=\"#6f6f6f\">FierceBiotech<\/font><\/li>\n<li><strong><a href=\"https:\/\/news.google.com\/stories\/CAAqOQgKIjNDQklTSURvSmMzUnZjbmt0TXpZd1NoTUtFUWpFb0tMWmpvQU1FYnB2TDFoTS1XMGNLQUFQAQ?oc=5\" >View full coverage on Google News<\/a><\/strong><\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>Is Tasigna (Or Nilotinib) Worth Testing For Parkinson&#8217;s? : Shots &#8211; Health News&nbsp;&nbsp;NPRHow Novartis&#8217; cancer drug Tasigna restores critical dopamine that&#8217;s lost to Parkinson&#8217;s disease&nbsp;&nbsp;FierceBiotechView full coverage on Google News<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-19586","post","type-post","status-publish","format-standard","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/eurojournalists.com\/index.php?rest_route=\/wp\/v2\/posts\/19586","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/eurojournalists.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/eurojournalists.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/eurojournalists.com\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/eurojournalists.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=19586"}],"version-history":[{"count":2,"href":"https:\/\/eurojournalists.com\/index.php?rest_route=\/wp\/v2\/posts\/19586\/revisions"}],"predecessor-version":[{"id":19643,"href":"https:\/\/eurojournalists.com\/index.php?rest_route=\/wp\/v2\/posts\/19586\/revisions\/19643"}],"wp:attachment":[{"href":"https:\/\/eurojournalists.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=19586"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/eurojournalists.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=19586"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/eurojournalists.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=19586"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}